Pexidartinib
Generic name: pexidartinib [ PEX-i-DAR-ti-nib ]
Brand name: Turalio
Dosage form: oral capsule (125 mg)
Drug class: Multikinase inhibitors
What is pexidartinib?
Pexidartinib is used in adults to treat giant cell tumor of the tendon sheath (also called tenosynovial giant cell tumor, or pigmented villonodular synovitis) not likely to improve with surgery.
Pexidartinib is available only under a special program. You must be registered in the program and understand the risks and benefits of pexidartinib.
Pexidartinib may also be used for purposes not listed in this medication guide.
Pexidartinib side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Stop using pexidartinib and call your doctor at once if you have dark urine or jaundice (yellowing of the skin or eyes).
Pexidartinib may cause serious side effects. Call your doctor at once if you have:
-
liver problems--loss of appetite, rash, fever, nausea, vomiting, stomach pain (upper right side), tiredness, itching, clay-colored stools.
Your treatments may be reduced, delayed, or permanently discontinued if you have certain side effects.
Common side effects of pexidartinib may include:
-
abnormal lab tests;
-
tiredness;
-
swelling inside or around your eyes;
-
changes in hair color;
-
rash, itching, hives, skin redness, acne; or
-
decreased or altered sense of taste.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Related/similar drugs
Romvimza
Romvimza is used to treat symptomatic tenosynovial giant cell tumor (TGCT) in adults when surgery ...
Turalio
Turalio (pexidartinib) is a kinase inhibitor for the treatment of tenosynovial giant cell tumor ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Warnings
Pexidartinib can harm your liver. You will need frequent blood tests to check your liver function before and during treatment with pexidartinib.
Stop using pexidartinib and call your doctor at once if you have dark urine or jaundice (yellowing of the skin or eyes).
Tell your doctor if you have other symptoms of liver problems, such as loss of appetite, stomach pain (upper right side), nausea, vomiting, tiredness, itching, or fever.
Before taking this medicine
Tell your doctor if you have or have ever had:
-
liver or kidney disease.
Pexidartinib can harm an unborn baby if the mother or the father is using this medicine.
-
If you are a woman, you may need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 1 month after your last dose.
-
If you are a man, use birth control if your sex partner is able to get pregnant. Keep using birth control for at least 1 week after your last dose.
-
Tell your doctor right away if a pregnancy occurs.
Pexidartinib can make birth control pills less effective. Ask your doctor about other birth control options such as an injection, implant, skin patch, vaginal ring, condom, diaphragm, cervical cap, or contraceptive sponge.
Pexidartinib may affect fertility in men or women. Pregnancy could be harder to achieve while either parent is using this medicine.
Do not breastfeed while using this medicine, and for at least 1 week after your last dose.
How should I take pexidartinib?
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Pexidartinib is usually taken twice per day with a low-fat meal (about 11 to 14 grams of fat).
Swallow the capsule whole and do not crush, chew, break, or open it.
If you vomit shortly after taking pexidartinib, do not take another dose. Take your next dose as scheduled.
You will need frequent blood tests to check your liver function before and during treatment with pexidartinib. Your next dose may be reduced, delayed, or permanently discontinued based on the results.
Your doctor will need to check your progress on a regular basis.
You may need to follow a special diet. Follow all instructions of your doctor or dietitian. Learn about the foods you should eat or avoid.
Keep the medicine in the original container, along with the canister of moisture-absorbing preservative. Store tightly closed at room temperature, away from moisture and heat.
Pexidartinib dosing information
Usual Adult Dose for Giant Cell Tumor of Bone:
250 mg orally 2 times a day
Treatment duration: Until disease progression or unacceptable toxicity
Comments:
-Take with a low-fat meal (approximately 11 to 14 grams of total fat).
-Taking with a high-fat meal increases the drug's concentrations and may increase the risk of adverse reactions, including hepatotoxicity.
Use: For symptomatic tenosynovial giant cell tumor associated with severe morbidity or functional limitations and not amenable to improvement with surgery
What happens if I miss a dose?
Skip the missed dose and use your next dose at the regular time. Do not use two doses at one time.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking pexidartinib?
Avoid taking a proton pump inhibitor, such as omeprazole, lansoprazole, pantoprazole, and others. Ask your doctor before taking any medicine to reduce stomach acid and take only the type your doctor recommends.
Grapefruit may interact with pexidartinib and cause side effects. Avoid consuming grapefruit products.
Avoid taking an herbal supplement containing St. John's wort.
Avoid eating foods high in fat (about 55 to 65 grams of total fat), or you may be more likely to have side effects.
Pexidartinib could make you sunburn more easily. Avoid sunlight or tanning beds. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outdoors.
What other drugs will affect pexidartinib?
Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.
Pexidartinib can harm your liver, especially if you also use certain medicines for infections, birth control, high cholesterol, seizures, pain, or arthritis (including Advil).
Some medicines can make pexidartinib much less effective or increase the risk of side effects when taken at the same time. If you take any of the following medicines, take them separately from your dose of pexidartinib:
-
If you take an antacid that contains aluminum, magnesium, or calcium--Take pexidartinib either 2 hours before or 2 hours after taking the antacid; or
-
stomach acid medicines (such as cimetidine, famotidine, nizatidine, and others)--take pexidartinib dose 2 hours before or 10 hours after you take the other medicine.
This list is not complete and many other drugs may affect pexidartinib. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
More about pexidartinib
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Cerner Multum, Inc. Version: 4.01.